A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Apolipoprotein B, Serum
Test CodeAPOBP
Alias/See Also
Epic: LAB3430
Mayo: APOLB
Apo B
APO-B
APOB
APOB-100
Apolipoprotein B-100
Apolipoprotein B+A1
Mayo: APOLB
Apo B
APO-B
APOB
APOB-100
Apolipoprotein B-100
Apolipoprotein B+A1
CPT Codes
82172
Preferred Specimen
Specimen Type: Serum
Collection Container: Serum gel
Specimen Volume: 1 mL
Minimum Volume
0.5 mL
Other Acceptable Specimens
Collection Container: Red top
Instructions
Centrifuge and aliquot serum into plastic vial. Send refrigerated.
Transport Container
Plastic vial
Specimen Stability
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 8 days | |
Frozen | 60 days | ||
Ambient | 24 hours |
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis | Reject |
Gross lipemia | OK |
Gross icterus | Reject |
Methodology
Automated Turbidimetric Immunoassay
Setup Schedule
Monday through Sunday
Report Available
1 to 3 days
Limitations
CAUTIONS
In very rare cases, gammopathy, type IgM (Waldenstrom macroglobulinemia) in particular, may cause unreliable results.
Reference Range
REFERENCE VALUES
Less than 2 years: Not established
2-17 years:
Acceptable: <90 mg/dL
Borderline high: 90-109 mg/dL
High: > or =110 mg/dL
Greater than 18 years:
Desirable: <90 mg/dL
Above Desirable: 90-99 mg/dL
Borderline high: 100-119 mg/dL
High: 120-139 mg/dL
Very high: > or =140 mg/dL
INTERPRETATION
Elevated apolipoprotein B (ApoB) confers increased risk of coronary artery disease. ApoB can be used as a therapeutic target analogous to non-HDL-C and LDL-C.
Extremely low values of ApoB (<48 mg/dL) are related to malabsorption of food lipids and can lead to polyneuropathy.
Clinical Significance
USEFUL FOR
Assessment of cardiovascular risk
Follow-up studies in individuals with basic lipid measures inconsistent with risk factors or clinical presentation
Definitive studies of cardiac risk factors in individuals with significant family histories of coronary artery disease or other increased risk factors
Confirmation of suspected abetalipoproteinemia or hypobetalipoproteinemia
CLINICAL INFORMATION
Apolipoprotein B (ApoB) is the primary protein component of low-density lipoprotein (LDL). LDL contains a variable amount of cholesterol, but each LDL contains exactly one ApoB protein. Therefore, ApoB is a more reliable indicator of circulating LDL compared to LDL cholesterol (LDL-C). ApoB has been demonstrated to perform equally with LDL particles measured by nuclear magnetic resonance spectroscopy.(1)
ApoB is strongly associated with increased risk of developing cardiovascular disease (CVD) and often outperforms LDL-C at predicting risk of coronary heart disease.(2-4) Patients with acceptable non-high-density lipoprotein cholesterol (HDL-C) or LDL-C but elevated ApoB remain at higher risk of developing CVD; conversely, patients with acceptably low ApoB but moderate non-HDL-C or LDL-C elevations are at a reduced risk for CVD.(5,6)
Finally, in 7 different placebo-controlled randomized clinical trials, on-statin reduction of ApoB was more closely related to CVD risk reduction than non-HDL-C or LDL-C.(7)
Performing Laboratory
Mayo Clinic Laboratories - Rochester
3050 Superior Drive NW
Rochester, MN 55901
Additional Information
Apolipoprotein B, Serum
Last Updated: December 18, 2023
Last Review: N. Wolford, December 18, 2023